How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Our client had recently conducted a series of clinical trials with its breakthrough cardiovascular product, resulting in outcomes data which had the potential to give it a more competitive edge and successfully differentiate it against their closest competitor.Communication strategies and marketing messages were to be crafted using the outcomes data which our client planned to launch at the European Society of Cardiology (ESC) annual congress. As a result, our client wanted to understand in detail the impact of their data on physicians’ perceptions of them.
Biosimilars 2015: Do our research findings suggest a step change in the market?
Q1 2015 has seen big changes for the biosimilar market, and with regulatory pathways now developed almost across the world we can see that biosimilars are becoming more widely accepted.
Laurent Chanroux, Research Director of Therapy Watch, looks at what has happened in 2015 to date and investigates how changes in the RA landscape are impacting rheumatologists’ likelihood to prescribe a biosimilar, using data taken from our Therapy Watch RA patient research study.
Expanding our US operations
We are delighted to announce that we have expanded our US operations, establishing offices in Boston, Los Angeles and San Francisco.
This is part of a major initiative to extend the company’s regional capacity within the US market. Research Partnership has appointed healthcare market research professionals Christine Naegle and Birgit Eschmann to run the company’s West Coast operations.